The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue

R Brisch, A Saniotis, R Wolf, H Bielau… - Frontiers in …, 2014 - frontiersin.org
Dopamine is an inhibitory neurotransmitter involved in the pathology of schizophrenia. The
revised dopamine hypothesis states that dopamine abnormalities in the mesolimbic and …

[HTML][HTML] Adenosine receptors and brain diseases: neuroprotection and neurodegeneration

CV Gomes, MP Kaster, AR Tomé, PM Agostinho… - … et Biophysica Acta (BBA …, 2011 - Elsevier
Adenosine acts in parallel as a neuromodulator and as a homeostatic modulator in the
central nervous system. Its neuromodulatory role relies on a balanced activation of inhibitory …

New translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and rats

TJ Bussey, A Holmes, L Lyon, AC Mar… - …, 2012 - Elsevier
We describe a touchscreen method that satisfies a proposed 'wish-list'of desirables for a
cognitive testing method for assessing rodent models of schizophrenia. A number of tests …

The emerging role for zinc in depression and psychosis

MA Petrilli, TM Kranz, K Kleinhaus, P Joe… - Frontiers in …, 2017 - frontiersin.org
Zinc participation is essential for all physiological systems, including neural functioning,
where it participates in a myriad of cellular processes. Converging clinical, molecular, and …

The pharmacology of neuroplasticity induced by non‐invasive brain stimulation: building models for the clinical use of CNS active drugs

MA Nitsche, F Müller‐Dahlhaus… - The Journal of …, 2012 - Wiley Online Library
The term neuroplasticity encompasses structural and functional modifications of neuronal
connectivity. Abnormal neuroplasticity is involved in various neuropsychiatric diseases, such …

Fast synaptic subcortical control of hippocampal circuits

V Varga, A Losonczy, BV Zemelman, Z Borhegyi… - science, 2009 - science.org
Cortical information processing is under state-dependent control of subcortical
neuromodulatory systems. Although this modulatory effect is thought to be mediated mainly …

Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2/3 receptor agonist pomaglumetad methionil in schizophrenia

BJ Kinon, BA Millen, L Zhang, DL McKinzie - Biological psychiatry, 2015 - Elsevier
Background Accumulating evidence indicates that glutamatergic tone in schizophrenia may
vary as a function of illness duration or medication history. We conducted an exploratory …

The cross-talk between the dopaminergic and the immune system involved in schizophrenia

PM Vidal, R Pacheco - Frontiers in pharmacology, 2020 - frontiersin.org
Dopamine is one of the neurotransmitters whose transmission is altered in a number of
neural pathways in the brain of schizophrenic patients. Current evidence indicates that these …

Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap

J Pratt, C Winchester, N Dawson, B Morris - Nature reviews Drug …, 2012 - nature.com
Although our knowledge of the pathophysiology of schizophrenia has increased, treatments
for this devastating illness remain inadequate. Here, we critically assess rodent models and …

TMS-EEG: An emerging tool to study the neurophysiologic biomarkers of psychiatric disorders

KX Cao, ML Ma, CZ Wang, J Iqbal, JJ Si, YX Xue… - …, 2021 - Elsevier
The etiology of psychiatric disorders remains largely unknown. The exploration of the
neurobiological mechanisms of mental illness helps improve diagnostic efficacy and …